These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 31479526)

  • 1. Exploring the link between tumour metabolism and succinate dehydrogenase deficiency: A
    Reichert T; Fakhry N; Lavieille JP; Amodru V; Sebag F; Romanet P; Loundou A; Castinetti F; Pacak K; Montava M; Taïeb D
    Clin Endocrinol (Oxf); 2019 Dec; 91(6):879-884. PubMed ID: 31479526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional characterization of nonmetastatic paraganglioma and pheochromocytoma by (18) F-FDOPA PET: focus on missed lesions.
    Gabriel S; Blanchet EM; Sebag F; Chen CC; Fakhry N; Deveze A; Barlier A; Morange I; Pacak K; Taïeb D
    Clin Endocrinol (Oxf); 2013 Aug; 79(2):170-7. PubMed ID: 23230826
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Feral CC; Tissot FS; Tosello L; Fakhry N; Sebag F; Pacak K; Taïeb D
    Eur J Nucl Med Mol Imaging; 2017 May; 44(5):812-821. PubMed ID: 27900521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 18F-FDG PET/CT as a predictor of hereditary head and neck paragangliomas.
    Blanchet EM; Gabriel S; Martucci V; Fakhry N; Chen CC; Deveze A; Millo C; Barlier A; Pertuit M; Loundou A; Pacak K; Taïeb D
    Eur J Clin Invest; 2014; 44(3):325-332. PubMed ID: 24422786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor multifocality with vagus nerve involvement as a phenotypic marker of SDHD mutation in patients with head and neck paragangliomas: A
    Amodru V; Romanet P; Scemama U; Montava M; Fakhry N; Sebag F; Castinetti F; Lavieille JP; Loundou A; Varoquaux A; Barlier A; Pacak K; Taïeb D
    Head Neck; 2019 Jun; 41(6):1565-1571. PubMed ID: 30584686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional imaging of SDHx-related head and neck paragangliomas: comparison of 18F-fluorodihydroxyphenylalanine, 18F-fluorodopamine, 18F-fluoro-2-deoxy-D-glucose PET, 123I-metaiodobenzylguanidine scintigraphy, and 111In-pentetreotide scintigraphy.
    King KS; Chen CC; Alexopoulos DK; Whatley MA; Reynolds JC; Patronas N; Ling A; Adams KT; Xekouki P; Lando H; Stratakis CA; Pacak K
    J Clin Endocrinol Metab; 2011 Sep; 96(9):2779-85. PubMed ID: 21752889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Head-to-head comparison between [
    He Q; Zhang Z; Zhang L; Zhang B; Long Y; Zhang Y; Liao Z; Zha Z; Zhang X
    Eur J Nucl Med Mol Imaging; 2024 Jun; 51(7):1989-2001. PubMed ID: 38300262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Head-to-head comparison between
    Heimburger C; Veillon F; Taïeb D; Goichot B; Riehm S; Petit-Thomas J; Averous G; Cavalcanti M; Hubelé F; Chabrier G; Namer IJ; Charpiot A; Imperiale A
    Eur J Nucl Med Mol Imaging; 2017 Jun; 44(6):979-987. PubMed ID: 28050631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 68Ga-DOTATATE PET/CT in the Localization of Head and Neck Paragangliomas Compared with Other Functional Imaging Modalities and CT/MRI.
    Janssen I; Chen CC; Taieb D; Patronas NJ; Millo CM; Adams KT; Nambuba J; Herscovitch P; Sadowski SM; Fojo AT; Buchmann I; Kebebew E; Pacak K
    J Nucl Med; 2016 Feb; 57(2):186-91. PubMed ID: 26564322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective comparison of (68)Ga-DOTATATE and (18)F-FDOPA PET/CT in patients with various pheochromocytomas and paragangliomas with emphasis on sporadic cases.
    Archier A; Varoquaux A; Garrigue P; Montava M; Guerin C; Gabriel S; Beschmout E; Morange I; Fakhry N; Castinetti F; Sebag F; Barlier A; Loundou A; Guillet B; Pacak K; Taïeb D
    Eur J Nucl Med Mol Imaging; 2016 Jul; 43(7):1248-57. PubMed ID: 26637204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [
    Pepponi M; Berti V; Fasciglione E; Montanini F; Canu L; Hubele F; Abenavoli E; Briganti V; Rapizzi E; Charpiot A; Taieb D; Pacak K; Goichot B; Imperiale A
    Eur J Nucl Med Mol Imaging; 2024 Jul; 51(9):2684-2694. PubMed ID: 38687372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FDG PET-CT imaging in head and neck paragangliomas: A centre experience.
    Boughdad S; O'Connor A; Cook GJ; Pike L; Connor S; Obholzer R; Warbey V
    Clin Endocrinol (Oxf); 2021 Aug; 95(2):315-322. PubMed ID: 33598922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Superiority of
    Jha A; Ling A; Millo C; Gupta G; Viana B; Lin FI; Herscovitch P; Adams KT; Taïeb D; Metwalli AR; Linehan WM; Brofferio A; Stratakis CA; Kebebew E; Lodish M; Civelek AC; Pacak K
    Eur J Nucl Med Mol Imaging; 2018 May; 45(5):787-797. PubMed ID: 29204718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Semiquantitative 123I-Metaiodobenzylguanidine Scintigraphy to Distinguish Pheochromocytoma and Paraganglioma from Physiologic Adrenal Uptake and Its Correlation with Genotype-Dependent Expression of Catecholamine Transporters.
    van Berkel A; Rao JU; Lenders JW; Pellegata NS; Kusters B; Piscaer I; Hermus AR; Plantinga TS; Langenhuijsen JF; Vriens D; Janssen MJ; Gotthardt M; Timmers HJ
    J Nucl Med; 2015 Jun; 56(6):839-46. PubMed ID: 25883126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative
    Amodru V; Guerin C; Delcourt S; Romanet P; Loundou A; Viana B; Brue T; Castinetti F; Sebag F; Pacak K; Taïeb D
    Eur J Nucl Med Mol Imaging; 2018 Feb; 45(2):278-282. PubMed ID: 28918451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Krebs cycle metabolite profiling for identification and stratification of pheochromocytomas/paragangliomas due to succinate dehydrogenase deficiency.
    Richter S; Peitzsch M; Rapizzi E; Lenders JW; Qin N; de Cubas AA; Schiavi F; Rao JU; Beuschlein F; Quinkler M; Timmers HJ; Opocher G; Mannelli M; Pacak K; Robledo M; Eisenhofer G
    J Clin Endocrinol Metab; 2014 Oct; 99(10):3903-11. PubMed ID: 25014000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Somatostatin Receptor-Directed PET/CT Can Differentiate Between Different Subtypes of Head and Neck Paragangliomas.
    Zhi Y; Gerhard-Hartmann E; Hartrampf PE; Weich A; Higuchi T; Bley TA; Hackenberg S; Hagen R; Rosenwald A; Scherzad A; Remde H; Fassnacht M; Werner RA; Serfling SE
    Clin Nucl Med; 2023 Nov; 48(11):923-927. PubMed ID: 37756444
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Kroiss AS; Uprimny C; Shulkin BL; Gruber L; Frech A; Url C; Riechelmann H; Sprinzl GM; Thomé C; Treglia G; Kjaer A; Fraedrich G; Virgolini IJ
    Nucl Med Biol; 2019 Apr; 71():47-53. PubMed ID: 31152973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and spectrum of SDHx mutations in pheochromocytoma and paraganglioma in patients from Belgium: an update.
    Persu A; Lannoy N; Maiter D; Mendola A; Montigny P; Oriot P; Vinck W; Garin P; Hamoir M; Vikkula M
    Horm Metab Res; 2012 May; 44(5):349-53. PubMed ID: 22566194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Staging and functional characterization of pheochromocytoma and paraganglioma by 18F-fluorodeoxyglucose (18F-FDG) positron emission tomography.
    Timmers HJ; Chen CC; Carrasquillo JA; Whatley M; Ling A; Eisenhofer G; King KS; Rao JU; Wesley RA; Adams KT; Pacak K
    J Natl Cancer Inst; 2012 May; 104(9):700-8. PubMed ID: 22517990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.